Mechanism of Bazi Bushen capsule in delaying the senescence of mesenchymal stem cells based on network pharmacology and experimental validation
- PMID: 38509951
- PMCID: PMC10950659
- DOI: 10.1016/j.heliyon.2024.e27646
Mechanism of Bazi Bushen capsule in delaying the senescence of mesenchymal stem cells based on network pharmacology and experimental validation
Abstract
Ageing is becoming an increasingly serious problem; therefore, there is an urgent need to find safe and effective anti-ageing drugs.
Aims: To investigate the effects of Bazi Bushen capsule (BZBS) on the senescence of mesenchymal stem cells (MSCs) and explore its mechanism of action.
Methods: Network pharmacology was used to predict the targets of BZBS in delaying senescence in MSCs. For in vitro studies, MSCs were treated with D-gal, BZBS, and NMN, and cell viability, cell senescence, stemness-related genes, and cell cycle were studied using cell counting kit-8 (CCK-8) assay, SA-β-galactosidase (SA-β-gal) staining, Quantitative Real-Time PCR (qPCR) and flow cytometry (FCM), respectively. Alkaline phosphatase (ALP), alizarin red, and oil red staining were used to determine the osteogenic and lipid differentiation abilities of MSCs. Finally, the expression of senescence-related genes and cyclin-related factors was detected by qPCR and western blotting.
Results: Network pharmacological analysis suggested that BZBS delayed cell senescence by interfering in the cell cycle. Our in vitro studies suggested that BZBS could significantly increase cell viability (P < 0.01), decrease the quantity of β-galactosidase+ cells (P < 0.01), downregulate p16 and p21 (P < 0.05, P < 0.01), improve adipogenic and osteogenic differentiation, and upregulate Nanog, OCT4 and SOX2 genes (P < 0.05, P < 0.01) in senescent MSCs. Moreover, BZBS significantly reduced the proportion of senescent MSCs in the G0/G1 phase (P < 0.01) and enhanced the expression of CDK4, Cyclin D1, and E2F1 (P < 0.05, P < 0.01, respectively). Upon treatment with HY-50767A, a CDK4 inhibitor, the upregulation of E2F1 was no longer observed in the BZBS group.
Conclusions: BZBS can protect MSCs against D-gal-induced senescence, which may be associated with cell cycle regulation via the Cyclin D1/CDK4/E2F1 signalling pathway.
Keywords: Bazi bushen capsule; Cell cycle; Cell senescence; Mesenchymal stem cells; Network pharmacology.
© 2024 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Bazi Bushen capsule attenuates cognitive deficits by inhibiting microglia activation and cellular senescence.Pharm Biol. 2022 Dec;60(1):2025-2039. doi: 10.1080/13880209.2022.2131839. Pharm Biol. 2022. PMID: 36263579 Free PMC article.
-
Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation.Heliyon. 2023 Jun 27;9(7):e17603. doi: 10.1016/j.heliyon.2023.e17603. eCollection 2023 Jul. Heliyon. 2023. PMID: 37449101 Free PMC article.
-
Bazi Bushen capsule attenuates cardiac systolic injury via SIRT3/SOD2 pathway in high-fat diet-fed ovariectomized mice.Heliyon. 2024 May 31;10(11):e32159. doi: 10.1016/j.heliyon.2024.e32159. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38912487 Free PMC article.
-
Bazi Bushen mitigates age-related muscular atrophy by alleviating cellular senescence of skeletal muscle.J Tradit Complement Med. 2024 Feb 3;14(5):510-521. doi: 10.1016/j.jtcme.2024.01.009. eCollection 2024 Sep. J Tradit Complement Med. 2024. PMID: 39262657 Free PMC article.
-
Bazi Bushen ameliorates age-related energy metabolism dysregulation by targeting the IL-17/TNF inflammatory pathway associated with SASP.Chin Med. 2024 Apr 9;19(1):61. doi: 10.1186/s13020-024-00927-9. Chin Med. 2024. PMID: 38594761 Free PMC article.
Cited by
-
Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.Heliyon. 2024 Sep 12;10(19):e37883. doi: 10.1016/j.heliyon.2024.e37883. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39381110 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Research Materials